Home > Newsroom > News Release
For Media

St. Elizabeth Cancer Institute Awarded Commission on Cancer Accreditation for 33 consecutive years

June 18 2015

St. Elizabeth Cancer Institute is proud to announce that is has been granted three-year accreditation with commendation by the Commission on Cancer of the American College of Surgeons. The cancer program at St. Elizabeth was first accredited by the Commission on Cancer in 1981 making this year the 33rd consecutive year of accreditation.

St. Elizabeth received the reaccreditation following a stringent certification process that ensures they are compliant with 34 standards measuring quality and comprehensive cancer care. The requirements cover everything from a multidisciplinary approach to care, state-of-the-art diagnostics, comprehensive support services and cancer registry management.

“We are very proud to be reaccredited by the Commission on Cancer. This designation affirms that we provide the highest level of quality care for cancer patients,” says Mike Hopkins, director of oncology services at CHI Health St. Elizabeth.

Receiving cancer care at an accredited hospital or facility ensures that patients will receive:

  • Comprehensive care including a complete range of state-of-the-art services and equipment
  • A multi-disciplinary team approach to coordinate the best available treatment options
  • Information about ongoing cancer clinical trials and new treatment options
  • Access to prevention and early detection programs, cancer education, and support services
  • A cancer registry that collects data on type and stage of cancers and treatment results and offers lifelong patient follow-up
  • Quality care close to home.

“Our accreditation is truly a team effort between everyone involved in our cancer program, including community physicians and providers,” adds Hopkins. “We appreciate everyone’s dedication and commitment to providing excellent cancer care in the community.”

It is estimated that more than 1.6 million new cases of cancer will be diagnosed in 2015 according to the American Cancer Society.